News Conference News ACC 2023 Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA Yael L. Maxwell March 09, 2023
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
News Conference News ACC 2021 TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI Yael L. Maxwell May 17, 2021
News Conference News ACC 2020 Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI Yael L. Maxwell March 28, 2020
News Conference News ACC 2019 No TREAT for Ticagrelor at 12 Months: Fibrinolysis Patients After STEMI Do Just as Well on Clopidogrel Shelley Wood March 19, 2019
News Conference News ACC 2019 Dropping Aspirin: Two Trials Explore P2Y12 Monotherapy After Short-term DAPT Post-PCI Yael L. Maxwell March 18, 2019
News Conference News ACC 2018 Too Soon for 6-Month DAPT, Say SMART-DATE Investigators, Despite Positive Trial Yael L. Maxwell March 12, 2018
News Conference News ACC 2018 ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More Shelley Wood March 12, 2018
News Conference News ACC 2018 ACC 2018, Day One: Live From Orlando! The ODYSSEY Begins Shelley Wood March 10, 2018
News Conference News ACC 2013 Rosuvastatin Helps Stave Off Contrast Nephropathy in NSTE-ACS Patients L.A. McKeown March 09, 2013
News Conference News ACC 2013 Cangrelor Consistently Comes Out Ahead of Clopidogrel in All PCI Patients Yael L. Maxwell March 09, 2013